Given that ROCK1 and ZIPK mediate important cellular functions and have been implicated in many pathological conditions, mainly vascular diseases such as hypertension, stroke, vasospasm, atherosclerosis, heart failure and pulmonary hypertension, as well as cancer, they are potentially useful therapeutic targets. Here, DAPK3 is linked to pulmonary arterial hypertension.